Heart disease and stroke, the principal components of
cardiovascular disease, are the first and third leading causes of
mortality in the United States, accounting for more than 40 percent
of all deaths. In addition to the traditional lipid profile, other
biomarkers such as homocysteine and lipoprotein (a) have been
gaining recognition as important independent or corroborative
indicators of cardiac risk. Inverness Medical Professional
Diagnostics offers both the Homocysteine*
and Macra Lp(a)* ELISA tests as well as
the breakthrough ACB® Test to measure
levels of Ischemia Modified Albumin, an ischemia marker for risk
stratification of chest pain patients.
View all cardiac risk assessment
tests
*Homocysteine and Macra® Lp(a) are
manufactured by Axis-Shield and Trinity Biotech, respectively, for
Inverness Medical.